Year: 2023
Type: review
Institutions: National University of Singapore, National University Health System, Inserm, Hôpitaux Universitaires de Strasbourg, Institute for Translational Medicine and Liver Disease, Université de Strasbourg, Ospedale di Parma, University of Auckland, Auckland City Hospital, Université de Lyon, Hospices Civils de Lyon, Centre de Recherche en Cancérologie de Lyon, University of Michigan, Michigan Medicine, University College London, University of Southern California
Language: English
Topic: Hepatitis B Virus Studies
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: GlaxoSmithKline, Gilead Sciences, Wellcome Trust, Arrowhead Pharmaceuticals, Moderna, European Commission, Agence Nationale de la Recherche, Institut National de la Santé et de la Recherche Médicale, National University Health System, Ipsen, Grifols, Genentech, Horizon 2020 Framework Programme, Abbott Diagnostics, National Medical Research Council
Awards: G1225849832, G1396127642, G1978585936, Par-delà les frontières, l'Université de Strasbourg, G2443614976, Façonner les talents en formation et en recherche à l'Université de Strasbourg, G2997830397, G3105035837, G3357951378, G3730343, Quantitation of circulating viral RNAs as a new biomaker of Hepatitis B functional cure, G3936374592, Integrative Molecular and Cellular Biology, Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities., G4937468798, G495187929, G521056402, G5295770283, G553018860, Harnessing tissue-resident CD8 T cells to manipulate hepatic immunity, G7719579985, G7994691760, Immune profiling to guide host-directed interventions to cure HBV infections
OpenAlex ID: W4315753997
